• 제목/요약/키워드: Patient Uniform

검색결과 91건 처리시간 0.028초

타액선 악성 종양 환자에 대한 치료성적 (Treatment Results in Patients with Salivary Gland Malignancy)

  • 송달원;안재현;손진식;김태종;안병훈
    • 대한두경부종양학회지
    • /
    • 제16권1호
    • /
    • pp.46-51
    • /
    • 2000
  • Objectives: Primary malignant tumors in the salivary glands are relatively rare. Because of the rarity and the different histopathologic patterns, it is difficult to establish a uniform treatment strategy. The prime treatment of salivary gland malignancy is the surgery, but the role of radiotherapy has been under debate. Radiation therapy combined with conservative surgical procedures may be as successful and perhaps more rational treatment than radical surgery alone. The aim of this study is to evaluate clinical pattern, incidence, treatment modality and outcome of the salivary gland maligancy. Materials and Methods: The medical records of 32 patients with malignant neoplasm of salivary gland who treated at the Keimyung university Dongsan hospital were analyzed retrospectively. Results: The overall 5 year survival rate was 77.9% stage I : 100%, stage II : 75%, stage III : 66.7%, stage IV : 55.6%). The 5 year survival rate according to tumor grade was 100% in low grade malignancy, 71.8% in high grade malignancy. The 5 year survival rate according to treatment modalities was as follows: Surgery only group was 83.3%, combined treatment group with surgery and posoperative radiation was 74.6%. Conclusion: The factors affecting prognosis is variable, but the stage at the time of diagnosis, site of lesion, tumor grade, histologic subtype were important factors. Surgery was the prime treatment tool and postoperative radiotherapy was also imperative in higher stage patient, high grade tumor, or patients with positive surgical margin.

  • PDF

외음부에 발생한 원발성 피부 선상 낭종성 암의 치험례 (A Case of Primary Cutaneous Adenoid Cystic Carcinoma at the Genital Area)

  • 정회준;손대구;권선영
    • Archives of Plastic Surgery
    • /
    • 제35권3호
    • /
    • pp.333-336
    • /
    • 2008
  • Purpose: Adenoid cystic carcinoma is a rare type of eccrine sweat gland carcinoma. Although it is mostly known as a neoplasm of the salivary gland, it could occur as a primary skin tumor. We present a patient with a primary cutaneous adenoid cystic carcinoma at the genital area. Methods: A 60-year-old man had a slowly growing 1 cm sized single tender mass near the left scrotum and he underwent excisional biopsy at a local clinic. A diagnosis of adenoid cystic carcinoma was made and thus he was transferred to our hospital. In physical examination, other specific findings were not detected except a linear scar caused by a previous skin biopsy near the left scrotum. In CT scan, PET-CT scan and endoscopy, there was no evidence of neoplasm in other organs. It was diagnosed as the primary cutaneous adenoid cystic carcinoma and then wide excisions were performed including total 4.5 cm margin of normal skin. Results: Microscopic findings revealed proliferation of tumor cell islands with cribriform or tubular patterns containing several round, pseudocystic structures. The tumor cells showed basaloid cells with uniform and small nuclei. Tumor cells infiltrated into the dermis and upper portion of subcutaneous tissue. There was multifocal perineural invasion of tumor cells. In postoperative 6 months, we found no recurrence and other complications. Conclusion: Herein we found a rare case of primary cutaneous adenoid cystic carcinoma at the genital area.

Gaucher병의 세포학적 소견 - 1예 보고 - (Cytologic Features of Gaucher's Disease in the Spleen - A Cese Report -)

  • 이헌경;박경신;김영신;이교영;강창석;심상인
    • 대한세포병리학회지
    • /
    • 제7권1호
    • /
    • pp.79-83
    • /
    • 1996
  • Gaucher's disease is an autosomal recessive disorder resulting from mutation at the glucocerebrosidase locus on chromosome 1q21. As a result, glucocerebroside accumulates principally in the phagocytic cells known as Gaucher cells. In our case, a five-year old girl was admitted with seven days' history of fever and abdominal distension. At physical examination the patient had hepatosplenomegaly. Laboratory tests revealed a hemoglobin concentration of 2.8g/L: platelet counts of $23,000/{\mu}l$: normal range of white cell and differential counts, and negative Coombs' test. Liver enzymes were normal. For the evaluation of hepatosplenomegaly, fine needle aspiration was performed blindly against the palpable spleen. Wet-fixed hematoxylin and eosin-stained smears are made. The smears from the spleen showed predominantly macrophages with abundant cytoplasm and rather small, uniform, often eccentric nuclei with small nucleoli. The multinucleated cells were often found. The cytoplasm was pale, with more or less distinct fibrillarity. The cells had the characteristic appearance of Gaucher cells. Gaucher cells were also found in the tissue section from the liver, spleen and lymph node and the bone marrow aspirate. The diagnosis was later confirmed by determination of bela-glucosidase activity in peripheral blood leucocytes. Fine needle aspiration of the spleen is considered as a convenient procedure with a low complication rate for the diagnosis of lysosomal storage disease.

  • PDF

가속도계를 이용한 광전용적맥파의 동잡음 제거 (A Study on Accelerometer Based Motion Artifact Reduction in Photoplethysmography Signal)

  • 강정훈;조백환;이종실;지영준;김인영;김선일
    • 대한의용생체공학회:의공학회지
    • /
    • 제28권3호
    • /
    • pp.369-376
    • /
    • 2007
  • With the convergence of ubiquitous networking and medical technologies, ubiquitous healthcare(U-Healthcare) service has come in our life, which enables a patient to receive medical services at anytime and anywhere. In the u-Healthcare environment, intelligent real-time biosignal aquisition/analysis techniques are inevitable. In this study, we propose a motion artifact cancelation method in portable photoplethysmography(PPG) signal aquisition using an accelerometer and an adaptive filter. A preliminary experiment represented that the component of the pedestrian motion artifact can be found under 5Hz in the spectral analysis. Therefore, we collected PPG signals under both simulated conditions with a motor that generates circular motion with uniform velocity (from 1 to 5Hz) and a real walking condition. We then reduced the motion artifact using a recursive least square adaptive filter which takes the accelerometer output as a noise reference. The results showed that the adaptive filter can remove the motion artifact effectively and recover peak points in PPG signals, which represents our method can be useful to detect heart rate in real walking condition.

Development and validation of a computational multibody model of the elbow joint

  • Rahman, Munsur;Cil, Akin;Johnson, Michael;Lu, Yunkai;Guess, Trent M.
    • Advances in biomechanics and applications
    • /
    • 제1권3호
    • /
    • pp.169-185
    • /
    • 2014
  • Computational multibody models of the elbow can provide a versatile tool to study joint mechanics, cartilage loading, ligament function and the effects of joint trauma and orthopaedic repair. An efficiently developed computational model can assist surgeons and other investigators in the design and evaluation of treatments for elbow injuries, and contribute to improvements in patient care. The purpose of this study was to develop an anatomically correct elbow joint model and validate the model against experimental data. The elbow model was constrained by multiple bundles of non-linear ligaments, three-dimensional deformable contacts between articulating geometries, and applied external loads. The developed anatomical computational models of the joint can then be incorporated into neuro-musculoskeletal models within a multibody framework. In the approach presented here, volume images of two cadaver elbows were generated by computed tomography (CT) and one elbow by magnetic resonance imaging (MRI) to construct the three-dimensional bone geometries for the model. The ligaments and triceps tendon were represented with non-linear spring-damper elements as a function of stiffness, ligament length and ligament zero-load length. Articular cartilage was represented as uniform thickness solids that allowed prediction of compliant contact forces. As a final step, the subject specific model was validated by comparing predicted kinematics and triceps tendon forces to experimentally obtained data of the identically loaded cadaver elbow. The maximum root mean square (RMS) error between the predicted and measured kinematics during the complete testing cycle was 4.9 mm medial-lateral translational of the radius relative to the humerus (for Specimen 2 in this study) and 5.30 internal-external rotation of the radius relative to the humerus (for Specimen 3 in this study). The maximum RMS error for triceps tendon force was 7.6 N (for Specimen 3).

Low-dose Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibition of EGFR Mutation-positive Lung Cancer: Therapeutic Benefits and Associations Between Dosage, Efficacy and Body Surface Area

  • Hirano, Ryosuke;Uchino, Junji;Ueno, Miho;Fujita, Masaki;Watanabe, Kentaro
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제17권2호
    • /
    • pp.785-789
    • /
    • 2016
  • A key drug for treatment of EGFR mutation-positive non-small cell lung cancer is epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI). While the dosage of many general anti-tumor drugs is adjusted according to the patient body surface area, one uniform dose of most TKIs is recommended regardless of body size. In many cases, dose reduction or drug cessation is necessary due to adverse effects. Disease control, however, is frequently still effective, even after dose reduction. In this study, we retrospectively reviewed the characteristics of 26 patients at Fukuoka University Hospital between January 2004 and January 2015 in whom the EGFR-TKI dose was reduced with respect to progression free survival and overall survival. There were 10 and 16 patients in the gefitinib group and the erlotinib group, respectively. The median progression-free survival in the gefitinib group and the erlotinib group was 22.4 months and 14.1 months, respectively, and the median overall survival was 30.5 months and 32.4 months, respectively. After stratification of patients by body surface area, the overall median progression-free survival was significantly more prolonged in the low body surface area (<1.45 m2) group (25.6 months) compared to the high body surface area (>1.45 m2) group (9.7 months) (p=0.0131). These results indicate that low-dose EGFR-TKI may sufficiently control disease without side effects in lung cancer patients with a small body size.

경관급식 유동액의 점도와 삼투압이 체외에서 비장관 튜브를 통한 흐름속도에 미치는 영향 (The Effects of viscosity and Osmolality of Enteral Solution on Flow Rates Through Nasogastric Tubes in Vitro)

  • 한경희
    • Journal of Nutrition and Health
    • /
    • 제26권6호
    • /
    • pp.793-803
    • /
    • 1993
  • This study was designed to measure viscosity, osmolality and in vitro flow rates via nasogastric tubes for 6 types of commercially available and 9 hospital-blenderized enteral solutions and to examine the effect of viscosity and osmolaility of enteral formula on the flow rates in gravity drip administration. Each solution was infused through 18, 16, 14, 12 French sizes of silicone rubber tube. Flow rates were measured six times at $25^{\circ}C$ using formula bags and drip sets hung at a uniform height on a intravenous drip stand with tube uniformly positioned in collecting container. Viscosity ranged widely from 16.0 to 195.5 cps with mean, 64.61$\pm$64.42 for hospital-blenderized formula while mean viscosity of commercial formula was 7.60$\pm$4.84 cps. Mean osmolality of commercial formula and hospital-blenderized formula were 370$\pm$100.80, 540.33$\pm$89.37 mOsm/kg respectively. There was negative relationship between viscosity of formula and flow rates through tubes but no significant relationship between flow rates and osmolalty. Some of hospital-blenderized formula was too viscous to be infused througth tube with gravity drip administration and the recipe of formula requires to be modiifed. On the other hand, commercial formula with the low viscosity flows too rapidly with large bore size tubes. Smaller size of tube must be selected for hyperosmolar solution to decrease possible side effects associated with tube feeding. Two kinds of regression equations for flow rates obtained according to viscosity and tube sizes were also presented for the purpose of practical uses. In conclusion, this study emphasizes that viscosity of fomula, osmolality, patient's tolerance and comfort, caloric density should be considered in the selection of tubes for gravify drip administration.

  • PDF

Evaluation of Dosimetric Effect and Treatment Time by Plan Parameters for Endobronchial Brachytherapy

  • Choi, Chang Heon;Park, Jong Min;Park, So-Yeon;Kang, SungHee;Cho, Jin Dong;Kim, Jung-in
    • 한국의학물리학회지:의학물리
    • /
    • 제28권2호
    • /
    • pp.39-44
    • /
    • 2017
  • This study aims to analyze dose distribution and treatment time of endobronchial brachytherapy (EBBT) by changing the position step size of the dwell position. A solid water phantom and an intraluminal catheter were used in the treatment plan. The treatment plans were generated for 3, 5, 7, and 10 cm treatment lengths, respectively. For each treatment length, the source position step sizes were set as 2.5, 5, and 10 mm. Three reference points were set 1 cm away from the central axis of the catheter, along the axis, for uniform dose distribution. Volumetric dose distribution was calculated to evaluate the dosimetric effect. The total radiation delivery time and total dwell time were estimated for treatment efficiency, which were increased with position step sizes. At half-life time, the differences between the position step sizes in the total radiation delivery time were 18.1, 15.4, 18.0, and 24.0 s for 3, 5, 7, and 10 cm treatment lengths, respectively. The dose distributions were more homogenous by increasing the position step sizes. The dose difference of the reference point was less than 10%. In brachytherapy, this difference can be negligible. For EBBT, the treatment time is the key factor while considering the patient status. To reduce the total treatment time, EBBT can be performed with 2.5 mm position step size.

척삭종 - 4례의 임상 및 병리학적 검색 - (Chordoma - A Clinicopathologic Review of 4 Cases -)

  • 최준혁;배영경;김미진;신덕섭;조길호
    • Journal of Yeungnam Medical Science
    • /
    • 제16권2호
    • /
    • pp.369-375
    • /
    • 1999
  • 1988년부터 1999년까지 영남대학교 의과대학 부속병원에서 척삭종으로 진단받은 4례를 대상으로 임상병리학적 특징을 분석하여 다음과 같은 결과를 얻었다. 환자의 연령은 57세에서 75세였고 평균연령은 63.5세였다. 4례 모두 천미골부에서 발생하였다. 종양의 평균 크기는 9.3cm 였다. 종양은 비교적 경계가 비교적 잘 지워지는 섬유성 격벽에 의해 나뉘어지는 분엽성, 점액성, 젤라틴 모습이었고, 조직학적으로 풍부한 점액성 기질과 거품모양의 공포를 갖는 담공포성 세포가 특정적으로 관찰되었다. 4례(100%)에서 종양세포들은 cytokeratin, EMA와 vimentin에 양성반응을 나타내었고, 1례(25.0%)는 S-100 protein에 양성 반응을 나타내었고, CEA에 대하여 모두 음성 반응이었다.

  • PDF

이하선에 발생한 기저세포선종의 치험례 (A Case of Basal Cell Adenoma in the Parotid Gland)

  • 이주철;박은수;곽정자
    • 대한두개안면성형외과학회지
    • /
    • 제13권2호
    • /
    • pp.151-155
    • /
    • 2012
  • Purpose: Basal cell adenoma of the salivary gland is an uncommon type of monomorphic adenoma. The most frequent location is parotid gland. It usually appears as a firm, mobile and slow-growing mass. Originally the term "basal cell adenoma" is described as a benign salivary gland tumor comprised of uniform appearing basaloid cells which are arranged in solid, trabecular, tubular, and membranous patterns. But the myxoid and chondroid mesenchymal like component as seen in pleomorphic adenoma is lacking in basal cell adenoma. We report a case of basal cell adenoma of parotid gland with review of the literatures. Methods: The 59-year-old female patient was referred to our department with a painless palpable mass in the left preauricular region for about 1 year. Movable and nontender subcutaneous mass was palpable. There was no evidence of cervical metastasis in computed tomography and ultrasonography. On fine needle aspiration cytology, pleomorphic adenoma was suspected. Under general anesthesia, superficial parotidectomy including tumor was performed. The biopsy result was basal cell adenoma. Results: Long-term follow-up for 54 months showed favorable result without evidence of recurrence except for temporary facial nerve weakness right after the surgery. Conclusion: Basal cell adenoma is the third most frequent benign tumor of the salivary gland, following pleomorphic adenoma and Warthin's tumor, although the incidence is low. The typical clinical feature of the basal cell adenoma is slowly growing, asymptomatic, and freely movable parotid mass. Basal cell adenoma should be also considered as a differential diagnosis of the parotid gland benign tumor.